|
|
|
|
|
|
|
|
132nd MAINE LEGISLATURE |
|
|
LD 1277 |
|
LR 2127(05) |
|
|
|
An Act Regarding
Controlled Substances Prescription Monitoring Activities |
|
Fiscal Note for
Bill as Engrossed with:
C "A" (H-551)
S "A" (S-680) to C "A" (H-551) |
|
Committee: Health and Human Services |
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fiscal Note |
|
|
|
|
|
|
|
|
|
|
FY 2025-26 |
FY 2026-27 |
Projections FY 2027-28 |
Projections FY 2028-29 |
| Net Cost
(Savings) |
|
|
|
|
|
|
General Fund |
|
$0 |
$77,000 |
$62,000 |
$62,000 |
|
|
|
|
|
|
|
| Appropriations/Allocations |
|
|
|
|
|
|
General Fund |
|
$0 |
$77,000 |
$62,000 |
$62,000 |
|
|
|
|
|
|
|
| Fiscal Detail
and Notes |
|
|
|
|
|
|
The bill includes
General Fund appropriations to Department of Health and Human Services of
$77,000 in fiscal year 2026-27 for database maintenance to implement the
exception of anabolic steroids from the Prescription Monitoring Program,
including one-time funding of $15,000 to purge records from the Controlled
Substances Prescription Monitoring Program. |
|
|
|
|
|
|
|